Clarifying Conflict of Interest

REFERENCES

• Abramson , J. 2004 . Overdo$ed America: The broken promise of American medicine , New York : HarperCollins .
   Google Scholar
• And the Winner Is—Pharmapologist . 2009 . Hooked: Ethics, medicine and pharma, April 19 . Available at: http://brodyhooked.blogspot.com/2009/04/and-winner-is-pharmapologist.html (accessed April 24, 2010)
   Google Scholar
• Angell , M. 2004 . The truth about the drug companies: How they deceive us and what to do about it , New York : Random House .
   Google Scholar
• AAMC Task Force . 2008 . Industry funding of medical education , Washington, DC : Association of American Medical Colleges . Available at: https://services.aamc.org/publications/showfile.cfm?file=version114.pdf&prd_id=232&prv_id=281&pdf_id=114 (accessed April 24, 2010)
   Google Scholar
• Avorn , J. 2004 . Powerful medicines: The benefits, risks, and costs of prescription drugs , New York : Knopf .
   Google Scholar
• Brennan , T. A. , Rothman , D. J. Blank , L. 2006 . Health industry practices that create conflicts of interest: A policy proposal for academic medical centers . Journal of the American Medical Association , 295 : 429 – 433 .
   PubMed Web of Science ®Google Scholar
• Brody , H. 2007 . Hooked: Ethics, the medical profession, and the pharmaceutical industry , Lanham, MD : Rowman and Littlefield .
   Google Scholar
• Brody , H. 2010 . Professional medical organizations and commercial conflicts of interest: Ethical issues . Annals of Family Medicine , 8 : 354 – 358 .
   PubMedGoogle Scholar
• Brody , H . In press . Conflict of interest between medicine and the pharmaceutical industry: Definitions and narratives . Journal of Medicine and Philosophy ,
   Google Scholar
• Campbell , E. G. , Gruen , R. L. M. Mountford , J. 2007 . A national survey of physician–industry relationships . New England Journal of Medicine , 356 : 1742 – 1750 .
   PubMed Web of Science ®Google Scholar
• Eichacker , P. Q. , Natanson , C. Danner , R. L. 2007 . Separating practice guidelines from pharmaceutical marketing [letter to editor and reply] . Critical Care Medicine , 35 : 2877 – 2878 .
   PubMedGoogle Scholar
• Epstein , R. A. 2007 . Conflicts of interest in health care: Who guards the guardians? . Perspectives in Biology and Medicine , 50 : 72 – 88 .
   PubMed Web of Science ®Google Scholar
• Erde , E. L. 1996 . “ Conflicts of interest in medicine: A philosophical and ethical morphology ” . In Conflicts of interest in clinical practice and research , Edited by: Speece , R. G. , Shimm , D. S. and Buchanan , A. E. 12 – 41 . New York : Oxford University Press .
   Google Scholar
• Figueiras , A. , Caamaño , F. and Gestal-Otero , J. J. 2000 . Influence of physician's education, drug information and medical-care settings on the quality of drugs prescribed . European Journal of Clinical Pharmacology , 56 : 747 – 753 .
   PubMed Web of Science ®Google Scholar
• Greenland , S. 2009 . Accounting for uncertainty about investigator bias: Disclosure is informative . Journal of Epidemiology and Community Health , 63 : 593 – 598 .
   PubMedGoogle Scholar
• Guyatt , G. and Rennie , D. 2002 . User's guide to the medical literature: A manual for evidence-based clinical practice , Chicago : AMA Press .
   Google Scholar
• Heim , L. 2010 . Identifying and addressing potential conflicts of interest: A professional medical organization's code of ethics . Annals of Family Medicine , 8 : 359 – 361 .
   PubMedGoogle Scholar
• Heim , L. and Henley , D. 2009 . Personal communication to author, November 30 .
   Google Scholar
• Hirsch , L. J. 2009 . Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals . Mayo Clinic Proceedings , 84 : 811 – 821 .
   PubMedGoogle Scholar
• Kassirer , J. P. 2005 . On the take: How medicine's complicity with big business can endanger your health , New York : Oxford University Press .
   Google Scholar
• Lenzer , J. 2004 . FDA bars own expert from evaluating risks of painkillers . British Medical Journal , 329 : 1203
   PubMedGoogle Scholar
• Lexchin , J. , Bero , L. A. , Djulbegovic , B. and Clark , O. 2003 . Pharmaceutical industry sponsorship and research outcome and quality: Systematic review . British Medical Journal , 326 : 1167 – 1170 .
   PubMed Web of Science ®Google Scholar
• Lo , B. and Field , M. J. , eds. 2009 . Conflict of interest in medical research, education and practice , Washington, DC : National Academies Press .
   Google Scholar
• Lurie , P. 2007 . Presentation before the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice . Public Citizen , November 5. Available at: http://www.citizen.org/publications/publicationredirect.cfm?ID=7553 (accessed April 24, 2010)
   Google Scholar
• May , C. F. 1961 . Selling drugs by “educating” physicians . Journal of Medical Education , 36 : 1 – 23 .
   PubMedGoogle Scholar
• Mertens , M. 2009 . Family doctors sign educational deal with Coca-Cola . Shots–NPR Health Blog , October 15. Available at: http://www.npr.org/blogs/health/2009/10/family_doctors_sign_educationa.html (accessed April 24, 2010)
   Google Scholar
• Murray , J. L. 2010 . Coke and the AAFP—The real thing or a dangerous liaison? . Family Medicine , 42 : 57 – 58 .
   PubMedGoogle Scholar
• Schafer , A. 2004 . Biomedical conflicts of interest: the sequestration thesis—Learning from the cases of Nancy Olivieri and David Healy . Journal of Medical Ethics , 30 : 8 – 24 .
   PubMed Web of Science ®Google Scholar
• Shaw , G. B. 1980 . The doctor's dilemma. , New York : Penguin .
   Google Scholar
• Shaywitz , D. A. and Stossel , T. P. 2009 . It's time to fight the ‘pharmascolds.’ . Wall Street Journal , April 8. Available at: http://online.wsj.com/article/SB123914780537299005.html (accessed April 24, 2010)
   Google Scholar
• Simmons , G. H. 1907 . The commercial domination of therapeutics and the movement for reform . Journal of the American Medical Association , 48 : 1645 – 1653 .
   Google Scholar
• Silverman , M. and Lee , P. R. 1974 . Pills, profits and politics. , Berkeley : University of California Press .
   Google Scholar
• Stell , L. K. 2010 . Avoiding over-deterrence in managing physicians’ relationships with industry . American Journal of Bioethics , 10 ( 1 ) : 27 – 29 .
   PubMed Web of Science ®Google Scholar
• Stossel , T. P. 2005 . Regulating academic–industrial research relationships—Solving problems or stifling progress? . New England Journal of Medicine , 353 : 1060 – 1064 .
   PubMed Web of Science ®Google Scholar
• Stossel , T. P. 2007a . Divergent views on managing clinical conflicts of interest . Mayo Clinic Proceedings , 82 : 1013 – 1014 .
   PubMedGoogle Scholar
• Stossel , T. P. 2007b . Regulation of financial conflicts of interest in medical practice and medical research: A damaging solution in search of a problem . Perspectives in Biology and Medicine , 50 : 54 – 71 .
   PubMed Web of Science ®Google Scholar
• Susman , J. 2009 . Do things really go better with Coke? . Journal of Family Practice , 58 : 630
   Google Scholar
• Wadman , M. 2009 . Money in biomedicine: The senator's sleuth . Nature , 461 : 330 – 334 .
   PubMedGoogle Scholar
• Wazana , A. 2000 . Physicians and the pharmaceutical industry: Is a gift ever just a gift? . Journal of the American Medical Association , 283 : 373 – 380 .
   PubMed Web of Science ®Google Scholar
• Weber , M. A. 2009 . Academic physicians confront a hostile world: The creation of ACRE . Journal of Clinical Hypertension , 11 : 533 – 536 .
   Google Scholar